An Official Website of the United States Government
Company Information:
Name:
VASCULOX, INC.
Address:
9256 LITZSINGER ROAD
SAINT LOUIS, MO 63144-
SAINT LOUIS, MO 63144-
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Treatment of Transplant Reperfusion with an Anti-CD47 Antibody
Award Year / Program / Phase:
2009 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Pamela A. Toymanning
Award Amount:
$203,191.00
Abstract:
DESCRIPTION (provided by applicant): Organ transplantation is one of the great success stories of modern medicine. However, the supply of suitable organs lags far behind the need and many patients die while waitlisted for organs. Current practice involves
donor preconditioning to stabilize organs… More
Anti-CD47 mAb Therapy to Improve Kidney Transplantation
Award Year / Program / Phase:
2011 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Pamela A. Toy-manning – 314-223-3799
Award Amount:
$276,232.00
Abstract:
DESCRIPTION (provided by applicant): Organ transplantation is one of the great success stories of modern medicine. However, the supply of suitable organs lags far behind the need and many patients die while waitlisted for organs. While there have been manyrecent strides in organ procurement,… More
Treatment of Transplant Reperfusion with CD47 antibody
Award Year / Program / Phase:
2012 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Pamela A. Toy-manning – 314-223-1400
Award Amount:
$1,533,751.00
Abstract:
DESCRIPTION (provided by applicant): Vasculox, Inc. is developing a humanized anti-CD47 mAb for reducing ischemia-reperfusion injury (IRI) in organ transplantation. In spite of improvements in surgical technique, organ preservation and immunosuppression, IRI remains a serious limitation and is… More